Biotech China 2014

Biology: Roche AG

Total Score People Score Events Score
14 13 13
Date Event Presentation Speakers
June 9, 2009 RNAi for Target Identification and Validation I. Surveying RNAi Opportunities: From Tools to Therapies Thomas Singer
February 9, 2009 Immunogenicity for Biologics 2009 A concerted and staggered implementation of different assays and methods for antibody screening and characterisation Julia Schleypen
October 22, 2008 Targeting Diabetes With Novel Therapeutics Antidiabetic Effects of Glucokinase Activators: From Benchside to Bedside Joseph Grimsby
August 18, 2008 Systems Integration in Biodefense REIMBURSEMENT AND REGULATORY ISSUES Kathleen Claessens
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SESSION D: SCIENTIFIC WRITING AND THE PUBLICATION PROCESS Tom Curran
Dealing with the Necessary Evils: Editors and Reviewers Tom Curran
Targeting the Hedgehog Pathway in Pediatric Brain Tumors Tom Curran
February 18, 2008 Fragment-based Lead Discovery Conference Fragment screening of drug targets by SPR and subsequent X-ray structural analysis Michael Hennig
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) In vitro RNAi Screening Strategies: RNAi Screening to Identify and Validate Therapeutic Targets in Metabolic Diseases (08:40-09:10) John Reidhaar-Olson
In vitro RNAi Screening Strategies (08:30-10:40) John Reidhaar-Olson
In vitro RNAi Screening Strategies: Chairperson’s Remarks (08:30-08:40) John Reidhaar-Olson
Roundtable Discussion Topic: In vitro RNAi Screening (07:30-08:30) John Reidhaar-Olson
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Rebecca A. Taub
SCREENING AGAINST MULTIPLE TARGETS: Featured Presentation - Is Repositioning a Viable Option for Creating Differentiated Medicines? (13:40-14:15) Rebecca A. Taub
PROFILING TO OPTIMIZE EFFICACY (08:30-14:00) Wolfgang Guba
PROFILING TO OPTIMIZE EFFICACY: Case Study - Chemogenomic Strategies for GPCR Hit Finding (11:15-11:45) Wolfgang Guba
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS: Featured Presentation - Is Repositioning a Viable Option for Creating Differentiated Medicines? (13:40-14:15) Rebecca A. Taub
SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Rebecca A. Taub
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY: Proteomic Analysis of Protein-Protein Interaction for Identification of Membrane Markers of Disease (11:30-12:00) Jinzhi Chen
Fifth Annual Protein Biomarkers; PROTEIN BIOMARKER DISCOVERY (08:30-16:00) Jinzhi Chen
September 10, 2007 Drug Development In China: Strategies for launching Discovery and Development activities Interactive Panel Discussion#3 (11:30-12:15) Edmund Tsuei
CASE STUDY: Place of China in Global Drug Development Strategy (14:15-14:45) Edmund Tsuei
August 4, 2007 Glucose Transporter Biology The Role of Ceramides in Insulin Resistance and Metabolic Disease Stefan Scherer
June 2, 2007 Proteases in Hemostasis and Vascular Biology THE DEVELOPMENT OF ACTIVE SITE DIRECTED FACTOR XA INHIBITORS AS ANTICOAGULANTS David W Banner
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.